HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Margaret A Schwarz Selected Research

member 1 small inducible cytokine subfamily E

4/2015The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
2/2015Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.
3/2014Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).
1/2013Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
1/2012Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II.
1/2012Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.
9/2011Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
7/2010Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer.
5/2010EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer.
4/2010Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Margaret A Schwarz Research Topics

Disease

20Neoplasms (Cancer)
04/2015 - 07/2004
13Pancreatic Neoplasms (Pancreatic Cancer)
05/2014 - 10/2007
10Adenocarcinoma
05/2014 - 04/2010
3Cicatrix (Scar)
02/2015 - 01/2004
3Stomach Neoplasms (Stomach Cancer)
11/2013 - 01/2013
3Bronchopulmonary Dysplasia
01/2012 - 02/2004
2Myocardial Ischemia (Ischemic Heart Diseases)
02/2015 - 01/2012
2Myocardial Infarction
02/2015 - 01/2004
2Lung Diseases (Lung Disease)
03/2014 - 01/2012
1Hyperoxia
06/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2015
1Pathologic Processes
04/2015
1Heart Failure
02/2015
1Fibrosis (Cirrhosis)
02/2015
1Inflammation
03/2014
1Emphysema
01/2012
1Thrombosis (Thrombus)
07/2004
1Cysts
06/2004
1Infarction
01/2004

Drug/Important Bio-Agent (IBA)

16member 1 small inducible cytokine subfamily EIBA
04/2015 - 01/2004
11gemcitabineFDA Link
03/2015 - 08/2009
4130-nm albumin-bound paclitaxelIBA
05/2014 - 01/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015 - 07/2004
3sunitinib (Sutent)FDA Link
05/2014 - 09/2011
3albumin-bound paclitaxelFDA Link
05/2014 - 01/2013
3NVP BEZ235IBA
11/2013 - 03/2012
3Proteins (Proteins, Gene)IBA
01/2011 - 01/2004
2bevacizumabFDA Link
05/2014 - 01/2012
2Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 10/2013
2docetaxel (Taxotere)FDA Link
10/2013 - 09/2011
2oxaliplatin (Eloxatin)FDA LinkGeneric
06/2013 - 01/2013
2Proteasome Endopeptidase Complex (Proteasome)IBA
07/2010 - 11/2009
1OxygenIBA
06/2015
1Messenger RNA (mRNA)IBA
06/2015
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
04/2015
1Staphylococcal Protein A (A, Protein)IBA
02/2015
1Angiogenesis InhibitorsIBA
05/2014
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
03/2014
1Carbon MonoxideIBA
03/2014
1TaxoidsIBA
11/2013
1CollagenIBA
10/2013
1Epirubicin (Ellence)FDA LinkGeneric
01/2013
1sorafenib (BAY 43-9006)FDA Link
01/2013
1StathminIBA
01/2013
1Insulin ReceptorIBA
12/2012
1BMS 754807IBA
12/2012
1Insulin (Novolin)FDA Link
12/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2011
1bortezomib (Velcade)FDA Link
07/2010
1Fibronectins (Fibronectin)IBA
04/2010
1Androgen Receptors (Androgen Receptor)IBA
10/2007
1HormonesIBA
10/2007
1Angiogenic ProteinsIBA
01/2004

Therapy/Procedure

7Heterologous Transplantation (Xenotransplantation)
11/2013 - 08/2009
3Drug Therapy (Chemotherapy)
03/2012 - 04/2010
1Intraperitoneal Injections
06/2013
1Myocardial Revascularization
01/2004